Latest Regulatory News

Horseshoe Metals advances its Horseshoe Lights copper-gold project with mining approval secured, site mobilization underway, and new drilling planned to expand resources.

TMK Energy has forged a strategic alliance with Beijing-based J-Energy to accelerate development planning for its Gurvantes XXXV Coal Seam Gas project in Mongolia, leveraging J-Energy’s technical expertise and Chinese market connections.

Immutep has received encouraging feedback from the FDA on its immunotherapy eftilagimod alfa combined with KEYTRUDA for patients with low PD-L1 expression in head and neck cancer, opening potential accelerated approval pathways.

Lincoln Minerals Limited has announced a pro-rata renounceable entitlement issue to raise approximately $1.5 million, partially underwritten by Mahe Capital Pty Ltd, to fund exploration across multiple projects including copper, uranium, graphite, and magnetite.

EBR Systems has won final CMS approval for New Technology Add-On Payment reimbursement, paving the way for Medicare coverage of its innovative WiSE cardiac pacing system starting October 2025.

DMC Mining Limited has extended the closing date of its public share offer to mid-September due to delays in securing exploration licences for key projects in Guinea. The company plans further regulatory updates as it awaits final approvals.

SRJ Technologies has secured $1.38 million from institutional investors in a fully underwritten entitlement offer, setting the stage for a strategic joint venture and acquisition in the Middle East. The company aims to raise an additional $1.15 million through a retail offer to support its growth ambitions.

Hot Chili Limited has announced a non-renounceable entitlement offer aiming to raise approximately A$14 million to advance its strategic partnering efforts and drilling programs. Eligible shareholders can subscribe for new shares at 60 cents each, with funds earmarked for exploration and corporate purposes.

FireFly Metals has secured environmental approval and reported exceptional metallurgical results for its Green Bay Copper-Gold Project in Canada, setting the stage for a production restart. With economic studies underway and strong funding, the project is rapidly advancing toward a scoping study release in early 2026.

Vitrafy Life Sciences reported strong FY25 progress with 75% sales growth, advanced cryopreservation technology development, and a robust cash position. The company outlines a clear commercialisation roadmap for FY26, including product launches and expanded U.S. operations.

Vitrafy Life Sciences reported a $32.7 million loss for FY25, driven by investments in its next-generation cryopreservation platform following a $35 million IPO and a $4.8 million government grant. The company is progressing commercialization efforts with key partnerships in human and animal health.

Credit Corp Group Limited has announced a fully franked ordinary dividend of AUD 0.36 per share for the six months ending June 2025, signaling steady returns for investors.